Abstract
Purpose: The hormonal response (flare-up) followingadministration of a standard dose (100 μg) or a low dose(25 μg) of gonadotropin releasing hormone agonist(GnRH-a) (Triptorelin) was compared in patients prior to an in vitrofertilization (IVF) cycle and during the early follicular phaseof a short-term IVF protocol.
Methods: The gonadotroph (FSH, LH) and steroid [estradiol(E2) and progesterone (P)] flare-up was studied on twoconsecutive cycles in 30 normo-ovulatory women. Patientswere randomized to receive either 25 or 100 μg of triptorelinfor three days at the beginning of the first cycle. Then doseswere switched according to a crossing over design in thesecond cycle.
Results: No significant difference in the magnitude of FSHand E2 release could be observed following administrationof the two doses of agonist whereas maximal plasma LHlevel was significantly reduced after injection of 25 μg oftriptorelin.
Conclusions: As compared to a standard dose, using a lowdose of GnRH-a induces an hormonal flare-up which seemsadequate for an optimal follicular recruitment.
Similar content being viewed by others
REFERENCES
Hughes EG, Sagle MA, Federkow DM, Van de Koppel P, Daya S, Collins JA: The routine use of Gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril 1992;58:888–896
Ben-Rafael Z, Lipitz S, Bider D, Mashiach S: Ovarian hyporestrates sponsiveness in combined gonadotropin-releasing hormone agonist and menotropin therapy is associated with low serum durfollicle-stimulating hormone levels. Fertil Steril 1991;55:272–275
Testard J, Lefebvre B, Gougeon A: Effects of Gonadotropin-releasing hormone agonist (GnRHa) on follicle and oocyte quality. Hum Reprod 1993;8:511–518
Feldberg D, Farhi J, Ashkenazi J, Dicker D, Shalev J, Ben-Rafael Z: Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels. Fertil Steril 1994;62:343–346
Olivennes F, Righini C, Fanchin R, Torrisi C, Hazout A, Glissant M, Fernandez H, Frydman R: A protocol using a low dose of Gonadotropin-releasing hormone agonist might be the best protocol for patients with high follicle stimulation hormone concentrations on day 3. Hum Reprod 1996;11:169–1172
Scott RT, Navot D: Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;6:880–885
Schoolcraft W, Schenker T, Stevens J, Wagley L, Gee M: Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril 1997;67:93–97
Surrey ES, Brower JA, Hill DM, Ramsey J, Surrey MW: Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419–424
Sandow J, Donnez J: Clinical pharmacokinetics of LHRH analogues. In LHRH Analogues in Gynecology, I Brosens, HS Jacobs, B Runnebaum (eds), Carnforth, UK Pathernon Publishing, 1990, pp 17–31
Broekmans FG, Hompes PGA, Lambalk CB, Shoute E, Broeders A, Schoemaker J: Short term pitutary desensitization: effects of different doses of the gonadotrophin-releasing hormone agonist triptorelin. Hum Reprod 1996;11:55–60
Janssens RMJ, Vermeiden JPW, Lambalk CB, Shats R, Schoemaker J: Gonadotrophin-releasing hormone agonist dose-dependency of pituitary desensitization during controlled of ovarian hyperstimulation in IVF. Hum Reprod 1998;13:2386–2391
Cédrin-Durnerin I, Bulwa S, Hervé F, Martin-Pont B, Uzan M, Hugues JN: The hormonal flare-up following gonadotropin-releasing hormone agonist administration is influenced by a progestogen pretreatment. Hum Reprod 1996;11:1859–1863
Lemay A, Metha AE, Tolis G, Faure N, Labrie F, Fazekas ATA: Gonadotropins and estradiol responses to single intranasal or subcutaneous administration of a luteinizing hormone-releasing hormone agonist in the early follicular phase. Fertil Steril 1983;39:668–673
Navot D, Rosenwaks Z, Anderson F, Hodgen GD: Gonadotropin-releasing hormone agonist induced ovarian hyperstimulation: Low-dose side effects in women and monkeys. Fertil Steril 1991;55:1069–1075
Deaton JL, Bauguess P, Huffman CS, Miller KA: Pituitary response to early follicular-phase minidose gonadotropin releasing hormone agonist (GnRHa) therapy: evidence for a second flare. J Assist Reprod Genet 1996;13:390–394
Scott RT, Carey KD, Leland M, Navot D: Gonadotropin responsiveness to ultralow-dose leuprolide acetate administration in baboons. Fertil Steril 1993;59:1124–1128
Hugues JN, Attalah M, Hervé F, Martin-Pont B, Kottler ML, Santarelli J: Effects of short-term GnRH agonist human menopausal Gonadotropin stimulation in patients pre-treated with progestogen. Hum Reprod 1992;7:1079–1084
Weil SJ, Vendola k, Zhou J, Adesanya OO, Wang J, Okafor J, Bondy CA: Androgen Receptor Gene Expression in the Primate Ovary: Cellular Localization, Regulation, and Functional Correlations. J Clin Endocrinol Metab 1998;83:2479–2485
Bergh C, Howles CM, Borg K, Hamberger LH, Josefsson B, Nilsson L, Wikland M: Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): Results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133–2139
Brzyski RG, Muasher SJ, Froesch K, Simonetti S, Jones GS, Rosenwaks Z: Follicular atresia associated with concurent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitement. Fertil Steril 1988;50:917–921
Loumaye E, Wankrieken L, Depreester S, Psalti I, de Coonan S, Thomas K: Hormonal changes by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyper-stimulation for in vitro fertilization and their consequences for embryonic development. Fertil Steril 1989;51:105–111
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bständig, B., Cédrin-Durnerin, I. & Hugues, J.N. Effectiveness of Low Dose of Gonadotropin Releasing Hormone Agonist on Hormonal Flare-Up. J Assist Reprod Genet 17, 113–117 (2000). https://doi.org/10.1023/A:1009470101732
Issue Date:
DOI: https://doi.org/10.1023/A:1009470101732